In Case You Missed It
5 Things You Must Know Before the Market Opens
Jim Cramer's Daily Booyah
Winners & Losers
Shares of the biotech, which researches cancer drugs, were up nearly 30% ahead of market's open.
Jim Cramer is bullish on AbbVie and Abbott Laboratories, but he's bearish on Sonic and Ionis Pharmaceuticals.
Cramer still thinks we need a rate hike, but he's ready for a backlash in some sectors -- and you should be, too.
This biotech company is trading at a bargain compared to its peer group.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.